Life Healthcare Group Holdings Limited
LTGHF · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.92 | 0.00 | -1.27 | -2.23 |
| FCF Yield | 0.71% | 16.31% | 0.54% | 7.06% |
| EV / EBITDA | 393.42 | 3.45 | 11.92 | 11.38 |
| Quality | ||||
| ROIC | 21.74% | 11.58% | 4.98% | 5.19% |
| Gross Margin | 23.29% | 69.78% | 28.31% | 20.82% |
| Cash Conversion Ratio | -0.37 | 1.37 | 3.23 | 1.71 |
| Growth | ||||
| Revenue 3-Year CAGR | -60.20% | -3.28% | -5.22% | 3.57% |
| Free Cash Flow Growth | -93.63% | 1,353.14% | -92.07% | -41.91% |
| Safety | ||||
| Net Debt / EBITDA | 63.20 | 0.44 | 3.66 | 3.30 |
| Interest Coverage | 6.38 | 6.87 | 4.22 | 7.74 |
| Efficiency | ||||
| Inventory Turnover | 2.71 | 16.55 | 36.38 | 15.37 |
| Cash Conversion Cycle | 152.36 | -14.27 | 24.99 | -20.14 |